866-997-4948(US-Canada Toll Free)

United States Angioedema Treatment Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 122 Pages

Notes:
Sales, means the sales volume of Angioedema Treatment
Revenue, means the sales value of Angioedema Treatment

This report studies sales (consumption) of Angioedema Treatment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AstraZeneca
F.Hoffmann-La Roche AG
Valeant Pharmaceuticals International
GlaxoSmithKline
AstraZeneca
Sanofi SA
MerckCo

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Antihistamines
Corticosteroids
Others
Split by applications, this report focuses on sales, market share and growth rate of Angioedema Treatment in each application, can be divided into
Hospitals
Clinics
Research Organizations?

Table of Contents

United States Angioedema Treatment Market Report 2017
1 Angioedema Treatment Overview
1.1 Product Overview and Scope of Angioedema Treatment
1.2 Classification of Angioedema Treatment
1.2.1 Antihistamines
1.2.2 Corticosteroids
1.2.3 Others
1.3 Application of Angioedema Treatment
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Research Organizations?
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Angioedema Treatment (2012-2022)
1.4.1 United States Angioedema Treatment Sales and Growth Rate (2012-2022)
1.4.2 United States Angioedema Treatment Revenue and Growth Rate (2012-2022)

2 United States Angioedema Treatment Competition by Manufacturers
2.1 United States Angioedema Treatment Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Angioedema Treatment Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Angioedema Treatment Average Price by Manufactures (2015 and 2016)
2.4 Angioedema Treatment Market Competitive Situation and Trends
2.4.1 Angioedema Treatment Market Concentration Rate
2.4.2 Angioedema Treatment Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Angioedema Treatment Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Angioedema Treatment Sales and Market Share by States (2012-2017)
3.2 United States Angioedema Treatment Revenue and Market Share by States (2012-2017)
3.3 United States Angioedema Treatment Price by States (2012-2017)

4 United States Angioedema Treatment Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Angioedema Treatment Sales and Market Share by Type (2012-2017)
4.2 United States Angioedema Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Angioedema Treatment Price by Type (2012-2017)
4.4 United States Angioedema Treatment Sales Growth Rate by Type (2012-2017)

5 United States Angioedema Treatment Sales (Volume) by Application (2012-2017)
5.1 United States Angioedema Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Angioedema Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Angioedema Treatment Manufacturers Profiles/Analysis
6.1 AstraZeneca
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Angioedema Treatment Product Type, Application and Specification
6.1.2.1 Antihistamines
6.1.2.2 Corticosteroids
6.1.3 AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 F.Hoffmann-La Roche AG
6.2.2 Angioedema Treatment Product Type, Application and Specification
6.2.2.1 Antihistamines
6.2.2.2 Corticosteroids
6.2.3 F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Valeant Pharmaceuticals International
6.3.2 Angioedema Treatment Product Type, Application and Specification
6.3.2.1 Antihistamines
6.3.2.2 Corticosteroids
6.3.3 Valeant Pharmaceuticals International Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Angioedema Treatment Product Type, Application and Specification
6.4.2.1 Antihistamines
6.4.2.2 Corticosteroids
6.4.3 GlaxoSmithKline Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Angioedema Treatment Product Type, Application and Specification
6.5.2.1 Antihistamines
6.5.2.2 Corticosteroids
6.5.3 AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi SA
6.6.2 Angioedema Treatment Product Type, Application and Specification
6.6.2.1 Antihistamines
6.6.2.2 Corticosteroids
6.6.3 Sanofi SA Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 MerckCo
6.7.2 Angioedema Treatment Product Type, Application and Specification
6.7.2.1 Antihistamines
6.7.2.2 Corticosteroids
6.7.3 MerckCo Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview

7 Angioedema Treatment Manufacturing Cost Analysis
7.1 Angioedema Treatment Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Angioedema Treatment

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Angioedema Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Angioedema Treatment Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Angioedema Treatment Market Forecast (2017-2022)
11.1 United States Angioedema Treatment Sales, Revenue Forecast (2017-2022)
11.2 United States Angioedema Treatment Sales Forecast by Type (2017-2022)
11.3 United States Angioedema Treatment Sales Forecast by Application (2017-2022)
11.4 Angioedema Treatment Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Angioedema Treatment
Table Classification of Angioedema Treatment
Figure United States Sales Market Share of Angioedema Treatment by Type in 2015
Figure Antihistamines Picture
Figure Corticosteroids Picture
Figure Others Picture
Table Application of Angioedema Treatment
Figure United States Sales Market Share of Angioedema Treatment by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Research Organizations? Examples
Figure United States Angioedema Treatment Sales and Growth Rate (2012-2022)
Figure United States Angioedema Treatment Revenue and Growth Rate (2012-2022)
Table United States Angioedema Treatment Sales of Key Manufacturers (2015 and 2016)
Table United States Angioedema Treatment Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Angioedema Treatment Sales Share by Manufacturers
Figure 2016 Angioedema Treatment Sales Share by Manufacturers
Table United States Angioedema Treatment Revenue by Manufacturers (2015 and 2016)
Table United States Angioedema Treatment Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Angioedema Treatment Revenue Share by Manufacturers
Table 2016 United States Angioedema Treatment Revenue Share by Manufacturers
Table United States Market Angioedema Treatment Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Angioedema Treatment Average Price of Key Manufacturers in 2015
Figure Angioedema Treatment Market Share of Top 3 Manufacturers
Figure Angioedema Treatment Market Share of Top 5 Manufacturers
Table United States Angioedema Treatment Sales by States (2012-2017)
Table United States Angioedema Treatment Sales Share by States (2012-2017)
Figure United States Angioedema Treatment Sales Market Share by States in 2015
Table United States Angioedema Treatment Revenue and Market Share by States (2012-2017)
Table United States Angioedema Treatment Revenue Share by States (2012-2017)
Figure Revenue Market Share of Angioedema Treatment by States (2012-2017)
Table United States Angioedema Treatment Price by States (2012-2017)
Table United States Angioedema Treatment Sales by Type (2012-2017)
Table United States Angioedema Treatment Sales Share by Type (2012-2017)
Figure United States Angioedema Treatment Sales Market Share by Type in 2015
Table United States Angioedema Treatment Revenue and Market Share by Type (2012-2017)
Table United States Angioedema Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Angioedema Treatment by Type (2012-2017)
Table United States Angioedema Treatment Price by Type (2012-2017)
Figure United States Angioedema Treatment Sales Growth Rate by Type (2012-2017)
Table United States Angioedema Treatment Sales by Application (2012-2017)
Table United States Angioedema Treatment Sales Market Share by Application (2012-2017)
Figure United States Angioedema Treatment Sales Market Share by Application in 2015
Table United States Angioedema Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Angioedema Treatment Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Angioedema Treatment Sales Market Share (2012-2017)
Table F.Hoffmann-La Roche AG Basic Information List
Table F.Hoffmann-La Roche AG Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table F.Hoffmann-La Roche AG Angioedema Treatment Sales Market Share (2012-2017)
Table Valeant Pharmaceuticals International Basic Information List
Table Valeant Pharmaceuticals International Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Valeant Pharmaceuticals International Angioedema Treatment Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Angioedema Treatment Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Angioedema Treatment Sales Market Share (2012-2017)
Table Sanofi SA Basic Information List
Table Sanofi SA Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi SA Angioedema Treatment Sales Market Share (2012-2017)
Table MerckCo Basic Information List
Table MerckCo Angioedema Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
Table MerckCo Angioedema Treatment Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Angioedema Treatment
Figure Manufacturing Process Analysis of Angioedema Treatment
Figure Angioedema Treatment Industrial Chain Analysis
Table Raw Materials Sources of Angioedema Treatment Major Manufacturers in 2015
Table Major Buyers of Angioedema Treatment
Table Distributors/Traders List
Figure United States Angioedema Treatment Production and Growth Rate Forecast (2017-2022)
Figure United States Angioedema Treatment Revenue and Growth Rate Forecast (2017-2022)
Table United States Angioedema Treatment Production Forecast by Type (2017-2022)
Table United States Angioedema Treatment Consumption Forecast by Application (2017-2022)
Table United States Angioedema Treatment Sales Forecast by States (2017-2022)
Table United States Angioedema Treatment Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *